Financials data is unavailable for this security.
View more
Year on year GlobeStar Therapeutics Corp 's net income fell 31.01% from a loss of 1.49m to a larger loss of 1.95m despite flat revenues.
| Gross margin | -- |
|---|---|
| Net profit margin | -- |
| Operating margin | -- |
| Return on assets | -38,103.72% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in USDView more
In 2023, cash reserves at GlobeStar Therapeutics Corp fell by 6.37k. Cash Flow from Financing totalled 199.40k or -- of revenues. In addition the company used 205.76k for operations while cash used for investing totalled .
| Cash flow per share | -0.0018 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -0.0015 |
|---|---|
| Tangible book value per share | -0.0015 |
More ▼
Balance sheet in USDView more
| Current ratio | 0.00 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | -- |
More ▼
